COMT and Parkinson disease: Opicapone is a third‐generation, potent, and selective peripheral COMT inhibitor that has proven generally well‐tolerated and efficacious in reducing OFF‐time in patients with PD and end‐of‐dose motor fluctuations [9, 10, 11].